A study in patients with the primary bone cancer osteosarcoma demonstrated that soluble B7-H3 levels were increased in patients with osteosarcoma compared to healthy individuals, and high levels of soluble B7-H3 correlated with tumor stage, metastases and shorter overall survival (OS) (24). Here, CD276 is linked to osteosarcoma.